buy photoshop for windows price of ms visio 2010 windows 2008 server pricing buy office outlook 2003 purchase ms money best price microsoft works 9.0 purchase windows 7 online buy corel painter essentials 4.0 buy cs3 cheap purchase microsoft outlook 2003 buy act premium 2009 cost of autocad map 3d buy windows xp pro full version buying microsoft office 2013 for mac adobe photoshop cs5 extended buy buy adobe fireworks download ms word 2003 buy buy cubase 6 online purchase quicken 2007 buy final cut pro 3.0 buy office visio professional 2007 solidworks 2008 price buy vmware fusion 3 cheap buy outlook 2007 online price of microsoft office 2008 for mac buy windows 7 not upgrade price of adobe acrobat 9 pro extended discount roxio creator pro 2010 buy indesign 2.0 best price autocad 2007 lt

Cancer Prevention Research

Mon, Nov 25, 2013

Oral Cancer News

 

Clinical and biochemical studies support smokeless tobacco’s carcinogenic potential in the human oral cavity

 
Source: American Association of Cancer Research
Published: November 9, 2013
By: Susan R. Mallery, Meng Tong, Gregory C. Michaels, Amber R. Kiyani, and Stephen S. Hecht

 

Abstract

In 2007, International Agency for Cancer Research presented compelling evidence that linked smokeless tobacco use to the development of human oral cancer. While these findings imply vigorous local carcinogen metabolism, little is known regarding levels and distribution of Phase I, II and drug egress enzymes in human oral mucosa. In the study presented here, we integrated clinical data, imaging and histopathologic analyses of an oral squamous cell carcinoma that arose at the site of smokeless tobacco quid placement in a patient. Immunoblot and immunohistochemical (IHC) analyses were employed to identify tumor and normal human oral mucosal smokeless tobacco-associated metabolic activation and detoxification enzymes. Human oral epithelium contains every known Phase I enzyme associated with nitrosamine oxidative bioactivation with ~2 fold inter-donor differences in protein levels. Previous studies have confirmed ~3.5 fold inter-donor variations in intraepithelial Phase II enzymes. Unlike the superficially located enzymes in non-replicating esophageal surface epithelium, IHC studies confirmed oral mucosal nitrosamine metabolizing enzymes reside in the basilar and suprabasilar region which notably is the site of ongoing keratinocyte DNA replication. Clearly, variations in product composition, nitrosamine metabolism and exposure duration will modulate clinical outcomes. The data presented here form a coherent picture consistent with the abundant experimental data that links tobacco-specific nitrosamines to human oral cancer.

 

* This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

 

Print Friendly
Be Sociable, Share!
, , ,

Leave a Reply

You must be logged in to post a comment.